New RNA drug takes aim at tough bladder cancer
Disease control
Recruiting now
This early-stage trial is testing a new drug called RAG-01 in 72 people with a type of bladder cancer that has not responded to standard therapy. The drug uses a small RNA molecule to try to control the cancer. The main goals are to check safety and find the right dose, while als…
Phase: PHASE1 • Sponsor: Ractigen Therapeutics. • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC